by Angela C. H. McDonald | Oct 6, 2011
Well before the creation of human induced pluripotent stem cells (iPSCs), a handful of researchers were using another reprogramming technique, somatic cell nuclear transfer (SCNT), with the hopes of deriving patient-specific pluripotent stem cell lines. The...
by Lisa Willemse | Sep 21, 2011
This morning’s news scan turned up yet another sad tale about the dangers of unproven stem cell therapies and a warning to consumers to once again be skeptical of the claims made by the many unscrupulous clinics operating abroad. For the most part, the article...
by Stem Cell Network | Sep 8, 2011
While ethical considerations can sometimes appear to take a back seat to lab results within the world of research, they are an integral part of any successful project -– or project proposal. Stem cell research is no exception –- in fact, given the vibrant and, at...
by Angela C. H. McDonald | Sep 2, 2011
Induced pluripotent stem cells (iPSCs) have great memories. They can remember whether they started out as a skin fibroblast, a blood cell or a pancreatic beta cell. Following reprogramming, iPSCs retain epigenetic (DNA packaging) signatures typical of their somatic...
by Stem Cell Network | Aug 16, 2011
A short time ago, Ed Yong blogged about a timeline he created on reprogrammed stem cells, which we’ve mentioned before in our own blog. It presented a good overview of the major papers that have defined the progress in this specific area and we found it interesting...
by Angela C. H. McDonald | Jul 21, 2011
Shinya Yamanaka’s first report of induced pluripotent stem cells (iPSCs) challenged what biologists thought they knew about terminal cell differentiation and caused a wave of excitement and hope for regenerative medicine applications. A second wave of excitement is...
Comments